new-jersey

Documents about new-jersey

• Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1#287531ClinicalTrials.gov
• Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections#876616ClinicalTrials.gov
• Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain#913935ClinicalTrials.gov
• A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)#279500ClinicalTrials.gov
• Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer#807509ClinicalTrials.gov
• Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer#915842ClinicalTrials.gov
• Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)#1033528ClinicalTrials.gov
• Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy#28567ClinicalTrials.gov
• PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice#808011ClinicalTrials.gov
• Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer#900505ClinicalTrials.gov
• A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)#831984ClinicalTrials.gov
• Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery#913095ClinicalTrials.gov
• Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects#861913ClinicalTrials.gov
• Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)#1047695ClinicalTrials.gov
• Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer#805520ClinicalTrials.gov
• History of the Catholic Church in Paterson, N.J. with an Account of the Celebration of the Fiftieth Anniversary of the Establishment of St. John's Church#50796Project Gutenberg
• Rutgers University Study of the Genetics of Pulmonary Hypertension#174986ClinicalTrials.gov
• Remote Ischemic Preconditioning In Abdominal Organ Transplantation#918525ClinicalTrials.gov
• Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer#916478ClinicalTrials.gov
• Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors#879788ClinicalTrials.gov
• Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)#826785ClinicalTrials.gov
• Sistematización de la experiencia de la terapeuta de desarrollo infantil dirigida a la primera infancia con autismo: una mirada a la intervención en el marco del programa de intervención temprana de New Jersey (NJEIS)#223895Biblioteca Digital
• Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)#879707ClinicalTrials.gov
• A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)#869078ClinicalTrials.gov
• Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer#181768ClinicalTrials.gov
• First Choice Women’s Resource Centers, Inc. v. Davenport#621368Supreme Court of the United States
• Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer#1007125ClinicalTrials.gov
• Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners#991838ClinicalTrials.gov
• Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability#882251ClinicalTrials.gov
• A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)#802132ClinicalTrials.gov
• Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer#980327ClinicalTrials.gov
• Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families#979819ClinicalTrials.gov
• Cimmer v Niessner#638457CanLII
• Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies#871838ClinicalTrials.gov
• Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer#899981ClinicalTrials.gov